loading...| Preferred Name | refractory cytopenia with multilineage dysplasia | |
| Synonyms |
RCMD |
|
| Definitions |
A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. A minority of cases progress to acute myeloid leukemia. (WHO, 2001) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C8574" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C8574" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000043315 |
|
| altLabel |
RCMD |
|
| cui |
C0796466 |
|
| Date last modified |
2011-06-02 |
|
| definition |
A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. A minority of cases progress to acute myeloid leukemia. (WHO, 2001) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C8574" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C8574" NCI Thesaurus) |
|
| Legacy PDQ ID |
7842 |
|
| NCI ID |
C8574 |
|
| notation |
CDR0000043315 |
|
| ORIG STY |
Neoplasm diagnosis |
|
| prefLabel |
refractory cytopenia with multilineage dysplasia |
|
| tui |
T191 |
|
| subClassOf |